FindTrial
Sign In

Comparision of two treatment modalities for patchy hair loss

Clinical and dermoscopic evaluation of therapeutic response to intralesional platelet rich plasma versus triamcinolone acetonide in alopecia areata.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/08/007218
Enrollment
40
Registered
2016-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- alopecia areata

Interventions

Intervention1: PLATELET RICH PLASMA: INTRALESIONAL INJECTIONS IN ALOPECIA AREATA 0.1 ml for each square centimeter once in every 3 weeks, total 4 sittings. Control Intervention1: TRIAMCINOLONE ACETON

Sponsors

LAKSHMI KANTH MALLADI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing for the study. •All the patients presenting with circumscribed patch of hair loss without any signs of inflammation or scarring. •Patients who have not taken any treatment for alopecia areata during the last 3 months. •Patients age more than 18 years

Exclusion criteria

Exclusion criteria: •Patients who are not willing for the study. •Patients with platelet count •Patients with pregnancy or lactation. •Extensive lesions (more than 5 lesions) or with secondary infection.

Design outcomes

Primary

MeasureTime frame
HAIR REGROWTH AS MEASURED BY HAIR REGROWTH SCALE AND DERMOSCOPIC CHANGES.Timepoint: 3rd,6th,9th and 12th week—

Secondary

MeasureTime frame
rate of hair regrowth, side effects, change on dermoscopyTimepoint: 0, 4, 8, 12 weeks—

Countries

India

Contacts

Public ContactDr Sukumar D

Father Muller medical college

drsukumard@rediffmail.com9343562354

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026